Functional analysis of a clonal deletion in an epidemic strain of Mycobacterium bovis reveals a role in lipid metabolism.

Previous work on the population structure of Mycobacterium bovis strains in Great Britain has identified highly successful clones which are expanding across the country. One such clone, designated M. bovis type 17, differs from all other members of the Mycobacterium tuberculosis complex in having a region of deletion, termed RDbovis(d)_0173, of seven genes between Mb1963c and Mb1971. Three of these genes have functions annotated in lipid metabolism. To explore the molecular basis for the success of this clone, we examined the impact of this deletion on lipid metabolism. While type 17 isolates had similar lipid composition to other M. bovis strains, their ability to incorporate propanoate into mycolic acids was remarkably low. When expressed as a reciprocal (the ratio of incorporation of label from acetate : propanoate into mycolic acids) the ratio was higher for all three type 17 field strains tested (mean: 18.90) than the values of 7.30 to 7.61 for other field strains (P < 0.002) and values < 6.50 for all other strains in the M. tuberculosis complex tested. The label from propanoate was diverted to pyruvate, at significantly higher levels in M. bovis type 17 than all other strains (P < 0.021). Complementation of M. bovis type 17 with an integrating cosmid, IE471, carrying the M. tuberculosis orthologues of Mb1963c-Mb1971 resulted in the ability of the recombinant strain to incorporate label from propanoate into mycolic acids in a manner similar to other strains. M. bovis type 17 : : IE471 labelled pyruvate from propanoate about four times more slowly than the parent strain. Thus, RDbovis(d)_0173 results in a profound effect on carbon metabolism, providing the ability to compensate for the inactivation of the ald and pykA genes, involved in pyruvate metabolism, that is seen in M. bovis (but not in M. tuberculosis). This shift in carbon metabolism may be a factor in the extraordinary clonal expansion reported for M. bovis type 17.

[1]  P. Wheeler.  Analysis of lipid biosynthesis and location. , 2009, Methods in molecular biology.

[2]  G. Kaplan,et al.  The Phenolic Glycolipid of Mycobacterium tuberculosis Differentially Modulates the Early Host Cytokine Response but Does Not in Itself Confer Hypervirulence , 2008, Infection and Immunity.

[3]  Digby F. Warner,et al.  Functional Characterization of a Vitamin B12-Dependent Methylmalonyl Pathway in Mycobacterium tuberculosis: Implications for Propionate Metabolism during Growth on Fatty Acids , 2008, Journal of bacteriology.

[4]  M. Daffé,et al.  4 A Comprehensive Overview of Mycolic Acid Structure and Biosynthesis , 2008 .

[5]  R. Wilkinson,et al.  A mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties. , 2007, Vaccine.

[6]  Richard S. Clifton-Hadley,et al.  Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis , 2006, Nature Reviews Microbiology.

[7]  Royston Goodacre,et al.  Metabolic fingerprints of Mycobacterium bovis cluster with molecular type: implications for genotype-phenotype links. , 2006, Microbiology.

[8]  James C Sacchettini,et al.  Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis , 2006, Molecular microbiology.

[9]  E. Muñoz-Elías,et al.  Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence , 2006, Molecular microbiology.

[10]  Stefan Niemann,et al.  Variable host-pathogen compatibility in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Cronan,et al.  Unexpected Functional Diversity among FadR Fatty Acid Transcriptional Regulatory Proteins* , 2005, Journal of Biological Chemistry.

[12]  M. Behr,et al.  Revisiting the Evolution of Mycobacterium bovis , 2005, Journal of bacteriology.

[13]  R. Brosch,et al.  Ancient Origin and Gene Mosaicism of the Progenitor of Mycobacterium tuberculosis , 2005, PLoS pathogens.

[14]  P. Wheeler,et al.  The pyruvate requirement of some members of the Mycobacterium tuberculosis complex is due to an inactive pyruvate kinase: implications for in vivo growth , 2005, Molecular microbiology.

[15]  P. Wheeler,et al.  Functional Demonstration of Reverse Transsulfuration in the Mycobacterium tuberculosis Complex Reveals That Methionine Is the Preferred Sulfur Source for Pathogenic Mycobacteria* , 2005, Journal of Biological Chemistry.

[16]  M. Reed,et al.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.

[17]  S. Cole,et al.  Genotypic Analysis of Mycobacterium tuberculosis in Bangladesh and Prevalence of the Beijing Strain , 2004, Journal of Clinical Microbiology.

[18]  N. Smith,et al.  The population structure of Mycobacterium bovis in Great Britain: Clonal expansion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Niederweis,et al.  Mycobacterial porins – new channel proteins in unique outer membranes , 2003, Molecular microbiology.

[20]  Julian Parkhill,et al.  The complete genome sequence of Mycobacterium bovis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Carolyn R Bertozzi,et al.  MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Behr,et al.  Mycobacterium bovis BCG Vaccines Exhibit Defects in Alanine and Serine Catabolism , 2003, Infection and Immunity.

[23]  Gurdyal S Besra,et al.  The methyl-branched fortifications of Mycobacterium tuberculosis. , 2002, Chemistry & biology.

[24]  D. V. van Aalten,et al.  The structural basis of acyl coenzyme A‐dependent regulation of the transcription factor FadR , 2001, The EMBO journal.

[25]  M. Glickman,et al.  The Mycobacterium tuberculosis cmaA2 Gene Encodes a Mycolic Acid trans-Cyclopropane Synthetase* , 2001, The Journal of Biological Chemistry.

[26]  M. Behr,et al.  A Point Mutation in the mma3 Gene Is Responsible for Impaired Methoxymycolic Acid Production in Mycobacterium bovis BCG Strains Obtained after 1927 , 2000, Journal of bacteriology.

[27]  M. Glickman,et al.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. , 2000, Molecular cell.

[28]  W. Jacobs,et al.  Survival of mice infected with Mycobacterium smegmatis containing large DNA fragments from Mycobacterium tuberculosis. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  B. Barrell,et al.  Use of a Mycobacterium tuberculosisH37Rv Bacterial Artificial Chromosome Library for Genome Mapping, Sequencing, and Comparative Genomics , 1998, Infection and Immunity.

[30]  G. Besra.  Preparation of cell-wall fractions from mycobacteria. , 1998, Methods in molecular biology.

[31]  D van Soolingen,et al.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology , 1997, Journal of clinical microbiology.

[32]  P. Anderson,et al.  Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+. , 1996, The Biochemical journal.

[33]  A. Sinskey,et al.  Recent advances in the physiology and genetics of amino acid-producing bacteria. , 1995, Critical reviews in biotechnology.

[34]  G. Besra,et al.  Identification of the apparent carrier in mycolic acid synthesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Brennan,et al.  Evidence for the nature of the link between the arabinogalactan and peptidoglycan of mycobacterial cell walls. , 1990, The Journal of biological chemistry.

[36]  C Ratledge,et al.  Use of carbon sources for lipid biosynthesis in Mycobacterium leprae: a comparison with other pathogenic mycobacteria. , 1988, Journal of general microbiology.

[37]  D. Minnikin,et al.  Systematic analysis of complex mycobacterial lipids , 1985 .

[38]  P. Kolattukudy,et al.  Isolation and Characterization of Acyl Coenzyme A Carboxylases from Mycobacterium tuberculosis and Mycobacterium bovis, Which Produce Multiple Methyl-Branched Mycocerosic Acids , 1982, Journal of bacteriology.

[39]  K. Bloch.  Control mechanisms for fatty acid synthesis in Mycobacterium smegmatis. , 2006, Advances in enzymology and related areas of molecular biology.

[40]  M. Collins,et al.  Thin-layer chromatographic analysis of mycolic acid and other long-chain components in whole-organism methanolysates of coryneform and related taxa. , 1976, Journal of general microbiology.

[41]  K. Bloch,et al.  Reversible inhibition of the fatty acid synthetase complex from Mycobacterium smegmatis by palmitoyl-coenzyme A. , 1975, The Journal of biological chemistry.